Media Coverage
Source: Daily Journal
Media Coverage
Press Contacts: Erik Cummins, Matt Hyams, Olivia Thomas
07.17.19
Pillsbury client Invitae Corp., a medical genetics company based in San Francisco, announced its intent to buy Jungla Inc. for approximately $50 million. Also based in San Francisco, Jungla is an artificial intelligence-driven biotechnology company.
Jungla’s cloud-based platform combines clinical knowledge with advances in functional genomics, biophysics, cellular engineering, machine learning and distributed systems. The company’s platform is designed to help clinicians and patients understand the results of genetic and genomic tests. The agreement is expected to help advance Invitae’s genetic variant interpretation and ability to deliver high-quality and more affordable genetic testing, the company said in a statement.
The cross-office, multidisciplinary Pillsbury team was led by San Diego associate Dusty Wolverton and included partners Michael Hird and Richard Blaylock in San Diego, Gabriella Lombardi and C. Brian Wainwright in Silicon Valley and Alicia McKnight in San Francisco. Also advising were senior associate Julie Park, associates Olivia Lugar, Kevin Lin and Margaret Beale-Wirsing and senior counsel Catherine Meyer.